Cardiac Implants
Medtronic touts real-world study of Reveal Linq heart monitor
SynCardia wins FDA nod for destination therapy trial
SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients. The Arizona company said it won the FDA’s approval to move ahead with the clinical study of its temporary Total Artificial Heart as a permanent transplant option. This is a big advance forward for […]
UPDATE: 3rd FDA panel vote barely favors Boston Scientific’s Watchman anti-stroke device
FDA panel offers mixed view on Boston Scientific Watchman device
FDA doubtful on new Watchman data from Boston Scientific
LoneStar Heart wins CE Mark for hydrogel heart implant
New data not so good for Boston Scientific’s Watchman anti-stroke device
Press Release: St. Jude Medical receives CE Mark approval for pacing lead labeling that will expand patient access to MRI scans
St. Jude chases MRI-friendly labeling for its CRM devices
St. Jude cries victory with its quadripolar leads
Medical device giant St. Jude Medical (NYSE:STJ) had high praise for its own quadripolar leads, saying that blow away any competition from older bipolar leads.